Ginkgo Bioworks Holdings (DNA) Change in Acquisitions & Divestments (2021 - 2026)
Ginkgo Bioworks Holdings' (DNA) quarterly Change in Acquisitions & Divestments came in at $58.0 million in Q2 2026, down 10.73% on a YoY basis from $65.0 million in Q2 2025, and down 46.39% quarter-over-quarter from $108.2 million in Q1 2026.
Analysis
Ginkgo Bioworks Holdings (DNA) Change in Acquisitions & Divestments (2021 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Change in Acquisitions & Divestments for 5 consecutive years, with $58.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Acquisitions & Divestments fell 10.73% year-over-year to $58.0 million; the trailing twelve-month figure through Jun 2026 stood at $260.7 million (up 275.22% YoY), and the FY2025 full-year result was $159.5 million, up 3429.17% from the prior year.
- Change in Acquisitions & Divestments slipped to $58.0 million in Q2 2026 per DNA's latest filing, from $108.2 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $108.2 million in Q1 2026 and bottomed at -$30000.0 in Q2 2022.
- Historically, Change in Acquisitions & Divestments has averaged $36.7 million across 4 years, with a median of $8.6 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments tumbled 129.13% in 2022, then jumped 15020.42% in 2025.
- Over 4 years, Change in Acquisitions & Divestments stood at -$30000.0 in 2022, then soared by 1993.33% to $568000.0 in 2024, then surged by 15020.42% to $85.9 million in 2025, then tumbled by 32.48% to $58.0 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $58.0 million, $108.2 million, and $85.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.99 Mn |
| Mar 31, 2026 | 108.18 Mn |
| Dec 31, 2025 | 85.88 Mn |
| Sep 30, 2025 | 8.64 Mn |
| Jun 30, 2025 | 64.96 Mn |
| Dec 31, 2024 | 568,000.00 |
| Sep 30, 2024 | 3.95 Mn |
| Jun 30, 2022 | -30,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Jun 30, 2021 | 103,000.00 |
| Mar 31, 2021 | 99,000.00 |